CA Stock MarketDetailed Quotes

HBP Helix BioPharma Corp

Watchlist
  • 0.970
  • 0.0000.00%
15min DelayMarket Closed Dec 23 16:00 ET
47.55MMarket Cap-0.92P/E (TTM)

Helix BioPharma Corp Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Oct 31, 2024
(FY)Jul 31, 2024
(Q4)Jul 31, 2024
(Q3)Apr 30, 2024
(Q2)Jan 31, 2024
(Q1)Oct 31, 2023
(FY)Jul 31, 2023
(Q4)Jul 31, 2023
(Q3)Apr 30, 2023
(Q2)Jan 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
27.32%1.59M
46.05%9.24M
145.89%5.26M
34.44%1.82M
-27.02%902K
-21.01%1.25M
4.74%6.33M
91.93%2.14M
4.15%1.36M
-35.83%1.24M
Selling and administrative expenses
-83.33%28K
761.20%2.58M
1,497.18%2.27M
-8.11%68K
-1.37%72K
1,192.31%168K
-49.75%299K
97.22%142K
-36.75%74K
-66.36%73K
-General and administrative expense
-83.33%28K
761.20%2.58M
1,497.18%2.27M
-8.11%68K
-1.37%72K
1,192.31%168K
-49.75%299K
97.22%142K
-36.75%74K
-66.36%73K
Research and development costs
39.20%1.32M
13.18%5.98M
53.85%2.86M
36.99%1.49M
-33.62%683K
-27.00%949K
16.22%5.28M
122.10%1.86M
15.44%1.08M
-31.67%1.03M
Other operating expenses
81.48%245K
-7.91%687K
-3.60%134K
36.36%270K
9.70%147K
-50.37%135K
-17.20%746K
-32.52%139K
-19.51%198K
-33.99%134K
Operating profit
-27.32%-1.59M
-46.05%-9.24M
-145.89%-5.26M
-34.44%-1.82M
27.02%-902K
21.01%-1.25M
-4.74%-6.33M
-91.93%-2.14M
-4.15%-1.36M
35.83%-1.24M
Net non-operating interest income (expenses)
-40.00%6K
-27.27%24K
200.00%9K
0
-135.71%-5K
66.67%10K
335.71%33K
400.00%3K
600.00%10K
255.56%14K
Non-operating interest income
-46.15%7K
-34.04%31K
66.67%10K
-85.71%2K
0.00%17K
30.00%13K
1,075.00%47K
50.00%6K
--14K
--17K
Non-operating interest expense
-66.67%1K
-50.00%7K
-66.67%1K
-50.00%2K
633.33%22K
-25.00%3K
-22.22%14K
-40.00%3K
100.00%4K
-66.67%3K
Other net income (expenses)
2,200.00%252K
-1,733.33%-49K
-47.06%-25K
-188.89%-8K
-86.49%5K
53.85%-12K
100.59%3K
93.73%-17K
121.95%9K
144.05%37K
Gain on sale of security
-83.33%-22K
-2,350.00%-49K
-47.06%-25K
-300.00%-8K
-86.49%5K
53.85%-12K
77.78%-2K
-666.67%-17K
-63.64%4K
242.31%37K
Special income (charges)
--274K
--0
--0
--0
----
--0
--5K
--0
--5K
----
-Less:Other special charges
---268K
----
----
----
----
----
----
----
----
----
-Gain on sale of property,plant,equipment
--6K
--0
--0
--0
----
--0
--5K
--0
--5K
----
Income before tax
-6.54%-1.34M
-47.28%-9.26M
-145.03%-5.28M
-36.95%-1.83M
23.88%-902K
21.87%-1.25M
4.17%-6.29M
-55.30%-2.15M
0.59%-1.34M
41.31%-1.19M
Income tax
Earnings from equity interest net of tax
Net income
-6.54%-1.34M
-47.28%-9.26M
-145.03%-5.28M
-36.95%-1.83M
23.88%-902K
21.87%-1.25M
4.16%-6.29M
-55.41%-2.15M
0.59%-1.34M
41.31%-1.19M
Net income continuous operations
-6.54%-1.34M
-47.28%-9.26M
-145.03%-5.28M
-36.95%-1.83M
23.88%-902K
21.87%-1.25M
4.16%-6.29M
-55.41%-2.15M
0.59%-1.34M
41.31%-1.19M
Noncontrolling interests
Net income attributable to the company
-6.54%-1.34M
-47.28%-9.26M
-145.03%-5.28M
-36.95%-1.83M
23.88%-902K
21.92%-1.25M
4.16%-6.29M
-55.41%-2.15M
0.59%-1.34M
41.31%-1.19M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-6.54%-1.34M
-47.28%-9.26M
-145.03%-5.28M
-36.95%-1.83M
23.88%-902K
21.92%-1.25M
4.16%-6.29M
-55.41%-2.15M
0.59%-1.34M
41.31%-1.19M
Diluted earnings per share
0.00%-0.15
-31.25%-1.05
-99.96%-0.1077
14.10%-0.043
57.02%-0.0215
-200.00%-0.15
-300.00%-0.8
-0.0538
0.00%-0.05
0.00%-0.05
Basic earnings per share
0.00%-0.15
-31.25%-1.05
-99.96%-0.1077
14.10%-0.043
57.02%-0.0215
-200.00%-0.15
-300.00%-0.8
-0.0538
0.00%-0.05
0.00%-0.05
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Oct 31, 2024(FY)Jul 31, 2024(Q4)Jul 31, 2024(Q3)Apr 30, 2024(Q2)Jan 31, 2024(Q1)Oct 31, 2023(FY)Jul 31, 2023(Q4)Jul 31, 2023(Q3)Apr 30, 2023(Q2)Jan 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 27.32%1.59M46.05%9.24M145.89%5.26M34.44%1.82M-27.02%902K-21.01%1.25M4.74%6.33M91.93%2.14M4.15%1.36M-35.83%1.24M
Selling and administrative expenses -83.33%28K761.20%2.58M1,497.18%2.27M-8.11%68K-1.37%72K1,192.31%168K-49.75%299K97.22%142K-36.75%74K-66.36%73K
-General and administrative expense -83.33%28K761.20%2.58M1,497.18%2.27M-8.11%68K-1.37%72K1,192.31%168K-49.75%299K97.22%142K-36.75%74K-66.36%73K
Research and development costs 39.20%1.32M13.18%5.98M53.85%2.86M36.99%1.49M-33.62%683K-27.00%949K16.22%5.28M122.10%1.86M15.44%1.08M-31.67%1.03M
Other operating expenses 81.48%245K-7.91%687K-3.60%134K36.36%270K9.70%147K-50.37%135K-17.20%746K-32.52%139K-19.51%198K-33.99%134K
Operating profit -27.32%-1.59M-46.05%-9.24M-145.89%-5.26M-34.44%-1.82M27.02%-902K21.01%-1.25M-4.74%-6.33M-91.93%-2.14M-4.15%-1.36M35.83%-1.24M
Net non-operating interest income (expenses) -40.00%6K-27.27%24K200.00%9K0-135.71%-5K66.67%10K335.71%33K400.00%3K600.00%10K255.56%14K
Non-operating interest income -46.15%7K-34.04%31K66.67%10K-85.71%2K0.00%17K30.00%13K1,075.00%47K50.00%6K--14K--17K
Non-operating interest expense -66.67%1K-50.00%7K-66.67%1K-50.00%2K633.33%22K-25.00%3K-22.22%14K-40.00%3K100.00%4K-66.67%3K
Other net income (expenses) 2,200.00%252K-1,733.33%-49K-47.06%-25K-188.89%-8K-86.49%5K53.85%-12K100.59%3K93.73%-17K121.95%9K144.05%37K
Gain on sale of security -83.33%-22K-2,350.00%-49K-47.06%-25K-300.00%-8K-86.49%5K53.85%-12K77.78%-2K-666.67%-17K-63.64%4K242.31%37K
Special income (charges) --274K--0--0--0------0--5K--0--5K----
-Less:Other special charges ---268K------------------------------------
-Gain on sale of property,plant,equipment --6K--0--0--0------0--5K--0--5K----
Income before tax -6.54%-1.34M-47.28%-9.26M-145.03%-5.28M-36.95%-1.83M23.88%-902K21.87%-1.25M4.17%-6.29M-55.30%-2.15M0.59%-1.34M41.31%-1.19M
Income tax
Earnings from equity interest net of tax
Net income -6.54%-1.34M-47.28%-9.26M-145.03%-5.28M-36.95%-1.83M23.88%-902K21.87%-1.25M4.16%-6.29M-55.41%-2.15M0.59%-1.34M41.31%-1.19M
Net income continuous operations -6.54%-1.34M-47.28%-9.26M-145.03%-5.28M-36.95%-1.83M23.88%-902K21.87%-1.25M4.16%-6.29M-55.41%-2.15M0.59%-1.34M41.31%-1.19M
Noncontrolling interests
Net income attributable to the company -6.54%-1.34M-47.28%-9.26M-145.03%-5.28M-36.95%-1.83M23.88%-902K21.92%-1.25M4.16%-6.29M-55.41%-2.15M0.59%-1.34M41.31%-1.19M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -6.54%-1.34M-47.28%-9.26M-145.03%-5.28M-36.95%-1.83M23.88%-902K21.92%-1.25M4.16%-6.29M-55.41%-2.15M0.59%-1.34M41.31%-1.19M
Diluted earnings per share 0.00%-0.15-31.25%-1.05-99.96%-0.107714.10%-0.04357.02%-0.0215-200.00%-0.15-300.00%-0.8-0.05380.00%-0.050.00%-0.05
Basic earnings per share 0.00%-0.15-31.25%-1.05-99.96%-0.107714.10%-0.04357.02%-0.0215-200.00%-0.15-300.00%-0.8-0.05380.00%-0.050.00%-0.05
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending CA Stocks
Big Five Big Five

The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.